Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Nathalie Audonnet has worked on the following 14 EPO patent applications which have been published in the last five years:

EP13002485

CLAY-BASED AROMATISED THERAPEUTIC COMPOSITION

IPC classification:
A61K 9/00, A61K 33/14, A61K 35/02
Applicant:
IPSEN PHARMA S.A.S.
Applicant:
Firmenich SA
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11290583

Novel pharmaceutical composition for a long acting growth hormone fusion protein (LAGH)

IPC classification:
A61K 38/27, A61P 5/00
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12798824

MACROCYCLIC LRRK2 KINASE INHIBITORS

IPC classification:
A61K 31/504, A61K 31/505, A61P 25/28, C07D 487/18, C07D 498/18, C07D 515/18
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Sakina Bounaga, De Clercq & Partners cvba
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12840868

PROCESS FOR THE SYNTHESIS OF THERAPEUTIC PEPTIDES

IPC classification:
C07K 1/04, C07K 7/06
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
EXAMINATION IN PROGRESS
EP13290156

Pharmaceutical composition for a sustained release of lanreotide

IPC classification:
A61K 9/00, A61K 38/31
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
APPLICATION REFUSED
EP12290189

Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release

IPC classification:
A61K 9/00, A61K 38/12, A61K 47/10
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13727192

AQUEOUS GELLING COMPOSITIONS OF SOLUBLE ACTIVE PHARMACEUTICAL PEPTIDES PROVIDING MODIFIED RELEASE

IPC classification:
A61K 9/00, A61K 38/00, A61K 38/12, A61K 47/10
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
EXAMINATION IN PROGRESS
EP11712680

TRANSDERMAL ADMINISTRATION OF PEPTIDES

IPC classification:
A61K 9/00, A61K 38/04, A61K 47/12
Applicant:
The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14747871

AQUEOUS SUSTAINED RELEASE COMPOSITIONS OF LHRH ANALOGUES

IPC classification:
A61K 38/09, A61K 47/02
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
GRANT OF PATENT INTENDED
EP14736812

PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE

IPC classification:
A61K 9/00, A61K 38/31
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
GRANT OF PATENT INTENDED
EP11794202

PROCESS FOR THE PREPARATION OF POLYMERS WITH VARIOUS STRUCTURES AND AMIDE INITIATING

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/51, A61K 9/70, A61K 47/34, C08G 63/08, C08G 63/685, C08G 63/81, C08G 63/82
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11739109

NEW OCTAPEPTIDIC COMPOUNDS AND THEIR USE IN THERAPY

IPC classification:
A61K 38/04, C07K 14/655
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15290069

COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD1 AND/OR PDL1 INHIBITOR, FOR USE AS A MEDICAMENT

IPC classification:
A61K 31/4704, A61K 39/00, A61K 45/06, A61P 35/00
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
APPLICATION REFUSED
EP16187114

SUSTAINED RELEASE FORMULATIONS COMPRISING VERY LOW MOLECULAR WEIGHT POLYMERS

IPC classification:
A61K 9/00, A61K 38/09, A61K 38/30, A61K 38/31, A61K 47/34, A61K 47/36
Applicant:
IPSEN PHARMA S.A.S.
Agent:
Nathalie Audonnet, IPSEN PHARMA S.A.S.
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature